Search

Your search keyword '"P. Brisou"' showing total 197 results

Search Constraints

Start Over You searched for: Author "P. Brisou" Remove constraint Author: "P. Brisou"
197 results on '"P. Brisou"'

Search Results

1. Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

2. Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma

3. Comorbidity burden on mortality in patients with systemic sclerosis

4. Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

5. S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA

6. S233: AXICABTAGENE CILOLEUCEL AS SECOND-LINE THERAPY FOR LARGE B-CELL LYMPHOMA IN TRANSPLANT-INELIGIBLE PATIENTS: FINAL ANALYSIS OF ALYCANTE, A PHASE 2 LYSA STUDY

7. Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

8. Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

9. Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models

11. Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients' knowledge to manage adverse effects.

13. Mycobacterium riyadhense Pulmonary Infection, France and Bahrain

15. Outbreak of Pertussis, Kabul, Afghanistan

16. The French Military influenza surveillance system (MISS): overview of epidemiological and virological results during four influenza seasons – 2008–2012

17. A prospective multicentre surveillance study to investigate the risk associated with contaminated sinks in the intensive care unit

18. Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

20. French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): An IFM Study from the Descar-T Registry

21. A case of multiple contamination with methylase ArmA-producing pathogens

22. Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells

23. Dermatitis and arthropods (Anobium punctatum and Cimex lectularius) in summer: three case reports

24. Mucormycose rhino-cérébrale à Rhizopus oryzae : à propos d’un cas

25. Syndromes myélodysplasiques érythroblastopéniques

26. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes

27. Blépharite chronique : quel rôle pour Demodex folliculorum ? À propos d’un cas

28. Moyens biologiques et stratégie diagnostique de la leptospirose neuroméningée. À propos d’un cas

29. Antiphospholipid antibodies in a family with dehydrated hereditary stomatocytosis

30. Infections à pneumocoque

31. Infecciones por neumococos

32. Mycobacterium riyadhense Pulmonary Infection, France and Bahrain

33. Détection simultanée d’une clonalité T et d’un transcrit FIP1L1-PDGFRA au cours d’un syndrome hyperéosinophilique

34. Syndrome d’activation macrophagique révélant une maladie de Hodgkin chez un sujet âgé

35. C'est long, comme lacunes !

36. Endocardite infectieuse à Kytococcus schroeteri

38. Outbreak of Pertussis, Kabul, Afghanistan

39. Observatoire régional du pneumocoque. Bilan 1995 de la région provençale

40. Septic nonunions of lower limb long bones: don't neglect Propionibacterium acnes!

41. Answer to December 2012 Photo Quiz

42. Watery diarrhea in an immune-competent traveler

43. Acinetobacter parvus bacteraemia community-acquired

44. Real World Data of Axicabtagene Ciloleucel As Second Line Therapy for Patients with Large B Cell Lymphoma: First Results of a Lysa Study from the French Descar-T Registry

45. Single-Cell Longitudinal Characterization of FL Heterogeneity and Residual Disease in the Bone Marrow from Low-Tumor Burden FL Enrolled in the Flirt Clinical Trial

46. A Single Cell Atlas of Diffuse Large B Cell Lymphomas Reveals Distinct Cellular States Predictive of Outcomes

47. Tazemetostat in Combination with R-CHOP in Patients with High-Risk, Frontline Follicular Lymphoma (Epi-RCHOP): A Phase II Study from the Lysa

48. Real-Word Experience of CAR T-Cells in Patients with Relapsed/Refractory Follicular Lymphoma : A Descart Registry Analysis from the Lysa

49. French Early Nationwide Idecabtagene Vicleucel (Ide-Cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy Experience in Patients with Relapsed/Refractory Multiple Myeloma (FENIX): Update of the IFM Study from the Descar-T Registry

50. Emergence of Highly-Plastic B Cell States Cooperates with Early Immune Microenvironment Remodeling to Drive Follicular Lymphomagenesis

Catalog

Books, media, physical & digital resources